{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:49:13Z","timestamp":1794473353100,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The safety of preoperative discontinuation of antiplatelet therapy for arterial thrombotic complications in non-cardiac, high-bleeding-risk surgery among patients receiving P2Y12 inhibitors remains poorly understood. This study compares the effect of preoperative discontinuation of antiplatelet therapy versus maintenance on thrombotic complications in patients receiving P2Y12 inhibitors who undergo minimally invasive surgery (MIS) for abdominal or pelvic cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cohort study, we identified patients receiving P2Y12 inhibitors who underwent planned MIS for abdominopelvic cancer from two hospital-based databases. They were divided into an interruption (exposure) group that discontinued antiplatelet therapy 5\u00a0days before surgery and a maintenance (control) group that continued therapy based on confirmed prescriptions less than 5\u00a0days before surgery. After adjusting for confounders, we evaluated the weighted risk ratios (RRs) for postoperative interventions over 90\u00a0days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1365 eligible patients were divided into an interruption group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091157) and a maintenance group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009208). The interruption group had increased risk of thrombotic complications (RR, 3.29; 95% confidence interval (CI), 1.15 to 9.41), particularly in postoperative coronary artery disease (RR, 5.30; 95% CI, 1.27 to 22.12). This elevated risk was notable among patients receiving dual antiplatelet therapy preoperatively. The interruption group did not show increased risk of postoperative ischemic stroke or peripheral arterial disease, nor did it substantially differ in hemostasis procedures, blood transfusions, or mortality. Notably, patients who discontinued antiplatelet therapy exhibited a higher overall risk of vascular events (RR, 2.54; 95% CI, 1.16 to 5.56).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Discontinuing antiplatelet therapy in patients receiving P2Y12 inhibitors more than 5\u00a0days before MIS was associated with an increased risk of postoperative coronary artery disease, without providing any benefit in terms of bleeding control or mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04634-0","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:35:03Z","timestamp":1768541703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between preoperative interruption of antiplatelet therapy and postoperative thrombotic risk after minimally invasive surgery for abdominopelvic cancer in patients treated with P2Y12 inhibitors"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-6932","authenticated-orcid":false,"given":"Masashi","family":"Kubota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-9427","authenticated-orcid":false,"given":"Satomi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6537-3068","authenticated-orcid":false,"given":"Takayuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0737","authenticated-orcid":false,"given":"Toshiki","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7490-5820","authenticated-orcid":false,"given":"Takayuki","family":"Anno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-9243","authenticated-orcid":false,"given":"Gaku","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7719-8679","authenticated-orcid":false,"given":"Satoshi","family":"Toshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-5913","authenticated-orcid":false,"given":"Yoshihide","family":"Inayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8558-4950","authenticated-orcid":false,"given":"Takanori","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5321-6014","authenticated-orcid":false,"given":"Takayuki","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3163-8723","authenticated-orcid":false,"given":"Ryoichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1069-2816","authenticated-orcid":false,"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-4071","authenticated-orcid":false,"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"4634_CR1","volume":"12;9(9)","author":"D Ilic","year":"2017","unstructured":"Ilic D, Evans SM, Allan CA, Jung JH, Murphy D, Frydenberg M. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer. Cochrane Database Syst Rev. 2017;12;9(9):CD009625.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"4634_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.euf.2022.12.001","volume":"9","author":"K-F Kowalewski","year":"2023","unstructured":"Kowalewski K-F, Wieland VLS, Kriegmair MC, Uysal D, Sicker T, Stolzenburg J-U, et al. Robotic-assisted versus laparoscopic versus open radical cystectomy-a systematic review and network meta-analysis of randomized controlled trials. Eur Urol Focus. 2023;9(3):480\u201390.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"4634_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/SLA.0000000000006006","volume":"279","author":"M Abu Hilal","year":"2024","unstructured":"Abu Hilal M, van Ramshorst TME, Boggi U, Dokmak S, Edwin B, Keck T, et al. The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS). Ann Surg. 2024Jan 1;279(1):45\u201357.","journal-title":"Ann Surg"},{"key":"4634_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijsu.2020.07.053","volume":"82","author":"GP Guerrini","year":"2020","unstructured":"Guerrini GP, Esposito G, Magistri P, Serra V, Guidetti C, Olivieri T, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: the largest meta-analysis. Int J Surg. 2020;82:210\u201328.","journal-title":"Int J Surg"},{"issue":"12","key":"4634_CR5","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/bjs.9902","volume":"102","author":"JH Lee","year":"2015","unstructured":"Lee JH, Nam B-H, Ryu KW, Ryu SY, Park YK, Kim S, et al. Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer. Br J Surg. 2015;102(12):1500\u20135.","journal-title":"Br J Surg"},{"issue":"1","key":"4634_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/bjs.8945","volume":"100","author":"BL Green","year":"2013","unstructured":"Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer: Conventionalversuslaparoscopically assisted surgery for colonic and rectal cancer. Br J Surg. 2013Jan;100(1):75\u201382.","journal-title":"Br J Surg"},{"issue":"4","key":"4634_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","volume":"28","author":"D Cibula","year":"2018","unstructured":"Cibula D, P\u00f6tter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, et al. The European Society of Gynaecological Oncology\/European Society for radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer. 2018May;28(4):641\u201355.","journal-title":"Int J Gynecol Cancer"},{"key":"4634_CR8","unstructured":"GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990\u20132019: an update from the Global Burden of Disease Study 2019. EClin Med. 2023;59(101936):101936."},{"issue":"1","key":"4634_CR9","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41598-022-05288-7","volume":"12","author":"K-S Huang","year":"2022","unstructured":"Huang K-S, He D-X, Tao Q, Wang Y-Y, Yang Y-Q, Zhang B, et al. Changes in the incidence and prevalence of ischemic stroke and associations with natural disasters: an ecological study in 193 countries. Sci Rep. 2022Feb 2;12(1):1808.","journal-title":"Sci Rep"},{"issue":"9","key":"4634_CR10","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: Contemporary epidemiology, management gaps, and future directions: A scientific statement from the American heart association. Circulation. 2021Aug 31;144(9):e171\u201391.","journal-title":"Circulation"},{"issue":"4","key":"4634_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.eururo.2023.04.004","volume":"84","author":"P Khetrapal","year":"2023","unstructured":"Khetrapal P, Wong JKL, Tan WP, Rupasinghe T, Tan WS, Williams SB, et al. Robot-assisted radical cystectomy versus open radical cystectomy: a systematic review and meta-analysis of perioperative, oncological, and quality of life outcomes using randomized controlled trials. Eur Urol. 2023;84(4):393\u2013405.","journal-title":"Eur Urol"},{"issue":"5","key":"4634_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1097\/JS9.0000000000000193","volume":"109","author":"J Ma","year":"2023","unstructured":"Ma J, Xu W, Chen R, Zhu Y, Wang Y, Cao W, et al. Robotic-assisted versus laparoscopic radical prostatectomy for prostate cancer: the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies. Int J Surg. 2023May 1;109(5):1350\u20139.","journal-title":"Int J Surg"},{"key":"4634_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijsu.2017.02.062","volume":"40","author":"Z Liu","year":"2017","unstructured":"Liu Z, Li X, Tian S, Zhu T, Yao Y, Tao Y. Superiority of robotic surgery for cervical cancer in comparison with traditional approaches: a systematic review and meta-analysis. Int J Surg. 2017;40:145\u201354.","journal-title":"Int J Surg"},{"issue":"7","key":"4634_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001Aug 16;345(7):494\u2013502.","journal-title":"N Engl J Med"},{"issue":"1","key":"4634_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013July 4;369(1):11\u20139.","journal-title":"N Engl J Med"},{"issue":"10293","key":"4634_CR16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","volume":"397","author":"B-K Koo","year":"2021","unstructured":"Koo B-K, Kang J, Park KW, Rhee T-M, Yang H-M, Won K-B, et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet. 2021June 26;397(10293):2487\u201396.","journal-title":"Lancet"},{"issue":"3","key":"4634_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018July 19;379(3):215\u201325.","journal-title":"N Engl J Med"},{"issue":"6","key":"4634_CR18","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1161\/STROKEAHA.107.504993","volume":"39","author":"K Toyoda","year":"2008","unstructured":"Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study: A prospective, multicenter, observational study. Stroke. 2008June;39(6):1740\u20135.","journal-title":"Stroke"},{"issue":"8","key":"4634_CR19","first-page":"753","volume":"6","author":"JM Siller-Matula","year":"2017","unstructured":"Siller-Matula JM, Petre A, Delle-Karth G, Huber K, Ay C, Lordkipanidz\u00e9 M, et al. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2017;6(8):753\u201370.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"16","key":"4634_CR20","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","volume":"125","author":"M Valgimigli","year":"2012","unstructured":"Valgimigli M, Campo G, Monti M, Vranckx P, Percoco G, Tumscitz C, et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial: A randomized multicenter trial. Circulation. 2012Apr 24;125(16):2015\u201326.","journal-title":"Circulation"},{"issue":"5","key":"4634_CR21","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, et al. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2022Nov;162(5):e207\u201343.","journal-title":"Chest"},{"issue":"19","key":"4634_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017316","volume":"9","author":"AJ Tafur","year":"2020","unstructured":"Tafur AJ, Clark NP, Spyropoulos AC, Li N, Kaplovitch E, MacDougall K, et al. Predictors of bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. J Am Heart Assoc. 2020Oct 20;9(19):e017316.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"4634_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2165\/00003088-200443140-00002","volume":"43","author":"S Harder","year":"2004","unstructured":"Harder S, Klinkhardt U, Alvarez JM. Avoidance of bleeding during surgery in patients receiving anticoagulant and\/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet. 2004;43(14):963\u201381.","journal-title":"Clin Pharmacokinet"},{"issue":"19","key":"4634_CR24","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","volume":"97","author":"P Albaladejo","year":"2011","unstructured":"Albaladejo P, Marret E, Samama C-M, Collet J-P, Abhay K, Loutrel O, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart. 2011;97(19):1566\u201372.","journal-title":"Heart"},{"issue":"1","key":"4634_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bja.2017.11.012","volume":"120","author":"A Rodriguez","year":"2018","unstructured":"Rodriguez A, Guilera N, Mases A, Sierra P, Oliva JC, Colilles C. Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery: association with adverse events. Br J Anaesth. 2018;120(1):67\u201376.","journal-title":"Br J Anaesth"},{"key":"4634_CR26","doi-asserted-by":"crossref","unstructured":"Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines: An update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016 Sept 6;134(10):e123\u201355.","DOI":"10.1161\/CIR.0000000000000404"},{"issue":"4","key":"4634_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.juro.2014.04.103","volume":"192","author":"DJ Culkin","year":"2014","unstructured":"Culkin DJ, Exaire EJ, Green D, Soloway MS, Gross AJ, Desai MR, et al. Anticoagulation and antiplatelet therapy in urological practice: ICUD\/AUA review paper. J Urol. 2014;192(4):1026\u201334.","journal-title":"J Urol"},{"issue":"5","key":"4634_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jama.2024.5880","volume":"332","author":"MD Lyons","year":"2024","unstructured":"Lyons MD, Pope B, Alexander J. Perioperative management of antithrombotic therapy. JAMA. 2024Aug 6;332(5):420\u20131.","journal-title":"JAMA"},{"key":"4634_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.urology.2020.08.095","volume":"148","author":"M Kubota","year":"2021","unstructured":"Kubota M, Matsuoka T, Yamasaki T, Kokubun H, Hagimoto H, Murata S, et al. Effect of continued perioperative anticoagulant therapy on bleeding outcomes following robot-assisted radical prostatectomy. Urology. 2021;148:151\u20138.","journal-title":"Urology"},{"issue":"1","key":"4634_CR30","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1038\/s41598-024-56570-9","volume":"14","author":"M Kubota","year":"2024","unstructured":"Kubota M, Kawakita M, Yoshida S, Kimura H, Sumiyoshi T, Yamasaki T, et al. Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy. Sci Rep. 2024Mar 11;14(1):5847.","journal-title":"Sci Rep"},{"issue":"6","key":"4634_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jgf2.367","volume":"21","author":"K Nagai","year":"2020","unstructured":"Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims databases sourced from Medical Institutions. J Gen Fam Med. 2020Nov 30;21(6):211\u20138.","journal-title":"J Gen Fam Med"},{"issue":"1","key":"4634_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11657-024-01428-w","volume":"19","author":"S Masuda","year":"2024","unstructured":"Masuda S, Fukasawa T, Otsuki B, Murata K, Shimizu T, Sono T, et al. Unchanged incidence of major adverse events amidst rising surgical interventions for osteoporotic vertebral fractures, 2015\u20132021. Arch Osteoporos. 2024Aug 6;19(1):71.","journal-title":"Arch Osteoporos"},{"issue":"10","key":"4634_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2183\/pjab.98.026","volume":"98","author":"S Yoshida","year":"2022","unstructured":"Yoshida S, Takeuchi M, Tanaka-Mizuno S, Mizuno K, Nakashima M, Fukasawa T, et al. Clinical epidemiology and pharmacoepidemiology studies with real-world databases. Proc Jpn Acad Ser B Phys Biol Sci. 2022;98(10):517\u201328.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"4634_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2188\/jea.JE20200288","volume":"31","author":"K Hayashida","year":"2021","unstructured":"Hayashida K, Murakami G, Matsuda S, Fushimi K. History and profile of Diagnosis Procedure Combination (DPC): Development of a real data collection system for acute inpatient care in Japan. J Epidemiol. 2021Jan 5;31(1):1\u201311.","journal-title":"J Epidemiol"},{"issue":"12","key":"4634_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70063","volume":"33","author":"T Anno","year":"2024","unstructured":"Anno T, Fukasawa T, Shinozaki T, Takeuchi M, Yoshida S, Kawakami K. Impact of early resumption of oral anticoagulation on recurrence after surgery for chronic subdural hematoma in patients with atrial fibrillation: a target trial emulation. Pharmacoepidemiol Drug Saf. 2024;33(12):e70063.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"4634_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12928-021-00833-z","volume":"37","author":"H Yokoi","year":"2022","unstructured":"Yokoi H, Oda E, Kaneko K, Matsubayashi K. Duration and clinical outcome of dual antiplatelet therapy after percutaneous coronary intervention: a retrospective cohort study using a medical information database from Japanese hospitals. Cardiovasc Interv Ther. 2022;37(3):465\u201374.","journal-title":"Cardiovasc Interv Ther"},{"issue":"2","key":"4634_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","volume":"37","author":"EC Hansson","year":"2016","unstructured":"Hansson EC, Jid\u00e9us L, \u00c5berg B, Bjursten H, Dreifaldt M, Holmgren A, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2016Jan 7;37(2):189\u201397.","journal-title":"Eur Heart J"},{"issue":"5","key":"4634_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/ejcts\/ezw149","volume":"50","author":"A Tom\u0161i\u010d","year":"2016","unstructured":"Tom\u0161i\u010d A, Schotborgh MA, Manshanden JSJ, Li WWL, de Mol BAJM. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. Eur J Cardiothorac Surg. 2016;50(5):849\u201356.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"8","key":"4634_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","volume":"1","author":"R Gherli","year":"2016","unstructured":"Gherli R, Mariscalco G, Dal\u00e9n M, Onorati F, Perrotti A, Chocron S, et al. Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting. JAMA Cardiol. 2016Nov 1;1(8):921.","journal-title":"JAMA Cardiol"},{"key":"4634_CR40","doi-asserted-by":"crossref","unstructured":"Ricciardi R, Seshadri-Kreaden U, Yankovsky A, Dahl D, Auchincloss H, Patel NM, et al. The COMPARE study: Comparing perioperative outcomes of oncologic minimally invasive laparoscopic, Da Vinci robotic, and open procedures: A systematic review and meta-analysis of the evidence: A systematic review and meta-analysis of the evidence. Ann Surg. 2024 [cited 2025 Mar 4]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39435549\/","DOI":"10.1097\/SLA.0000000000006572"},{"issue":"23","key":"4634_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5657","volume":"367","author":"RJ Desai","year":"2019","unstructured":"Desai RJ, Franklin JM. Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ. 2019;367(23):l5657.","journal-title":"BMJ"},{"issue":"3","key":"4634_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/EDE.0000000000000457","volume":"27","author":"P Ding","year":"2016","unstructured":"Ding P, VanderWeele TJ. Sensitivity analysis without assumptions. Epidemiology. 2016;27(3):368\u201377.","journal-title":"Epidemiology"},{"issue":"4","key":"4634_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: Introducing the E-value. Ann Intern Med. 2017Aug 15;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"key":"4634_CR44","volume":"18;7(7)","author":"SR Lewis","year":"2018","unstructured":"Lewis SR, Pritchard MW, Schofield-Robinson OJ, Alderson P, Smith AF. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2018;18;7(7):CD012584.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"4634_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/jama.299.5.532","volume":"299","author":"PM Ho","year":"2008","unstructured":"Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008Feb 6;299(5):532\u20139.","journal-title":"JAMA"},{"issue":"20","key":"4634_CR46","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1093\/eurheartj\/ehs202","volume":"33","author":"M Charlot","year":"2012","unstructured":"Charlot M, Nielsen LH, Lindhardsen J, Ahlehoff O, Olsen A-MS, Hansen ML, et al. Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study. Eur Heart J. 2012;33(20):2527\u201334.","journal-title":"Eur Heart J"},{"issue":"1","key":"4634_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/SLA.0000000000006136","volume":"280","author":"T Fujikawa","year":"2024","unstructured":"Fujikawa T, Hasegawa S, Takahashi R, Naito S, Kaihara S, Uryuhara K, et al. Management of patients receiving antiplatelet therapy during Gastroenterological Surgery: A multicenter prospective cohort study (GSATT): A multicenter prospective cohort study (GSATT). Ann Surg. 2024July 1;280(1):82\u201390.","journal-title":"Ann Surg"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04634-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04634-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04634-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:04:57Z","timestamp":1770771897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04634-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4634"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04634-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kyoto University Graduate School and Faculty of Medicine (approval number: R4384-1). Because all data used in this study were anonymized, the requirement for individual informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study used retrospective, anonymized data obtained under data use agreements. No individual-level identifiable data are presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Satomi Yoshida has received a consulting fee from TOYOTA Konpon Research Institute, Inc. Toshiki Fukasawa was previously employed by the Department of Digital Health and Epidemiology at Kyoto University with support from Eisai Co., Ltd. and Kyowa Kirin Co., Ltd.; he has received research funds from AstraZeneca K.K. and the Pfizer Health Research Foundation, consulting fees from Asahi Kasei Pharma Corporation, JMDC Inc., and Real World Data Co., Ltd., and an honorarium from the Research Institute of Healthcare Data Science; and his spouse is employed by MSD K.K. Takanori Yanai received personal fees from Real World Data Co., Ltd. Koji Kawakami receives research funds from AstraZeneca, Eisai Co., Ltd., Kyowa Kirin Co., Ltd., OMRON Corporation, and Toppan Inc.; consulting fees from Advanced Medical Care Inc., JMDC Inc., Shin Nippon Biomedical Laboratories Ltd., and Ubicom Holdings Inc.; executive compensation from Cancer Intelligence Care Systems, Inc. and Mytreya Inc.; and honoraria from Pharma Business Academy and Co., Ltd and SANSHO Co., Ltd. The other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}